The Biocompatibility of eugenol after an intraosseous implantation

The biocompatibility of the Eugenol, as one of the commonest root canal filling (RCF), material was evaluated through an intraosseous implantation of this material in the mandible of the Syrian hamsters. Forty Syrian hamsters were divided into 5 groups, 8 animals in each group, group 1 as control, a...

Full description

Saved in:
Bibliographic Details
Main Author: Al-Sarraf M. Khulood (Author)
Format: Book
Published: College of Pharmacy / Mustansiriyah University, 2006-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_4da4bd127b634f1cb5b3efb5a48a7795
042 |a dc 
100 1 0 |a Al-Sarraf M. Khulood  |e author 
245 0 0 |a The Biocompatibility of eugenol after an intraosseous implantation 
260 |b College of Pharmacy / Mustansiriyah University,   |c 2006-06-01T00:00:00Z. 
500 |a 10.32947/ajps.v3i1.409 
500 |a 1815-0993 
500 |a 2959-183X 
520 |a The biocompatibility of the Eugenol, as one of the commonest root canal filling (RCF), material was evaluated through an intraosseous implantation of this material in the mandible of the Syrian hamsters. Forty Syrian hamsters were divided into 5 groups, 8 animals in each group, group 1 as control, and group 2, 3, 4, 5 as experimental groups. After the animal was anesthetised, the skin was reflected and a hole of 2mm. diameter X 2mm. depth was drilled in all the hamster mandibles. A mixture of Eugenol and Zinc oxide as a paste was placed in that hole of each animal of the experimental groups and left for different periods, 7 days, 14 days, 21 days, and 28 days. After the hamsters were sacrificed, a histological examination of the implantation site was performed, the results showed that Eugenol elicited a severe inflammatory reaction at day 7, and this inflammatory reaction is increased to become more severe at day 14, and the reaction begin to  decrease with the 21 day giving about the same histopathological picture of after 7 days to become moderate after 28 days. Our conclusion is that the Eugenol is a biologically irritant material even after 4 weeks of its intraosseous implantation. 
546 |a EN 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Al-Mustansiriyah Journal of Pharmaceutical Sciences, Vol 3, Iss 1 (2006) 
787 0 |n https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/409 
787 0 |n https://doaj.org/toc/1815-0993 
787 0 |n https://doaj.org/toc/2959-183X 
856 4 1 |u https://doaj.org/article/4da4bd127b634f1cb5b3efb5a48a7795  |z Connect to this object online.